Schedule 13G ownership disclosure

Beam Therapeutics Inc

Common Stock · CUSIP: 07373V105

Event date: 2024-09-30

Filing-level shares
6,531,099.00
Percent of class
7.92%
  • ARK Investment Management LLC

    Shares: 6,531,099.00 · Class: 7.92%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-002732
Form type
SCHEDULE 13G/A
Filer
ARK Investment Management LLC
CIK
CIK 1697748
Filed
Jan 10, 2025
Reporting period
Sep 30, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub